对于在亚急性或慢性阶段的二夸特诱导的有毒脑损伤的高压氧疗法
Ping Wang1,2, Cui-Fei Luo1, Ting Li1,2
1Department of Emergency Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Clinical toxicology (Philadelphia, Pa.)
|November 11, 2025
概括
高压氧气疗法可能会改善二夸特诱导的有毒脑损伤患者的神经结果. 这种治疗在小型病例系列中显示出减少大脑病变和改善患者功能的潜力.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 高压医学的高压医学.
背景情况:
- 由于氧化应激和神经炎症,迪卡特诱导的有毒脑损伤带来了重大挑战.
- 这种情况往往导致广泛的中枢神经系统损伤和不良预后.
研究的目的:
- 评估高压氧气疗法 (HBOT) 在二夸特诱导的毒性脑损伤的亚急性或慢性阶段的疗效.
- 评估HBOT后的神经恢复和成像变化.
主要方法:
- 对三名用HBOT治疗的二夸特诱导的有毒脑损伤患者的回顾性分析.
- 对临床数据,实验室发现和HBOT前后的神经成像进行审查.
主要成果:
- 接受HBOT的患者在治疗后的神经成像上显示了中枢神经系统病变的减少.
- 三分之二的患者经历了神经功能评分的改善和巴塞尔指数的修改,实现了临床独立.
结论:
- 初步发现表明,HBOT可能有利于在亚急性/慢性二引发的脑损伤中神经恢复.
- 需要进一步的大规模前性研究来确认HBOT对这种疾病的疗效和安全性.
相关概念视频
01:30Acute Respiratory Failure-III
749
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
749
01:29Acute Respiratory Failure-V
440
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
440